Detalhe da pesquisa
1.
Inoculum effects of cefepime/zidebactam (WCK 5222) and ertapenem/zidebactam (WCK 6777) for Enterobacterales in relation to ß-lactamase type and enhancer effect, as tested by BSAC agar dilution.
J Antimicrob Chemother;
77(7): 1916-1922, 2022 06 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35368056
2.
Inherent colistin resistance in genogroups of the Enterobacter cloacae complex: epidemiological, genetic and biochemical analysis from the BSAC Resistance Surveillance Programme.
J Antimicrob Chemother;
75(9): 2452-2461, 2020 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32514538
3.
Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance.
J Antimicrob Chemother;
72(10): 2704-2707, 2017 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29091185
4.
Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles.
J Antimicrob Chemother;
72(8): 2278-2289, 2017 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28520867
5.
Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis.
J Neurol Sci;
421: 117270, 2021 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33349466
6.
DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder.
J Neurol;
268(8): 3031-3041, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33106889
7.
Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review.
J Neurol Sci;
415: 116886, 2020 Aug 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32428759
8.
Correction to: DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder.
J Neurol;
268(8): 3042, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34152486
9.
In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci.
Int J Antimicrob Agents;
41(3): 213-7, 2013 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23298432